Aardvark Therapeutics’ (NASDAQ:AARD – Get Free Report) quiet period is set to expire on Tuesday, March 25th. Aardvark Therapeutics had issued 5,888,000 shares in its IPO on February 13th.

RBC Capital analyst Brian Abrahams initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating and $21 price target Aardvark Therapeutics has a shot at establishing a key role for ...

A new AI weather prediction system, Aardvark Weather, can deliver accurate forecasts tens of times faster and using thousands of times less computing power than current AI and physics-based ...

But this year, the Red Sox manager wanted to get a sense of his team first, Garrett Crochet in particular. The Sox traded for Crochet in December, sending four prospects to the White Sox for the ...

In this article, we are going to take a look at where Aardvark Therapeutics, Inc. (NASDAQ:AARD) stands against other stocks with at least $10 million in insider spending recently. Since Donald ...

The new model, called Aardvark Weather, replaces the supercomputers and human experts used by forecasting agencies with a single artificial intelligence model that can run on a standard desktop ...

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic ...

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...

Aardvark, a novel machine learning-based weather prediction system, teases a future where supercomputers are optional for forecasting - but don't pull the plug just yet. Academics affiliated with the ...

Named Aardvark Weather, researchers say the new weather forecasting system is tens of times faster compared to current AI and physics based systems while consuming “thousands of times less computing ...